Stent-Graft for Abdominal Aortic Aneurysm
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this clinical trial is to assess and evaluate the safety and efficacy of the Treovance Stent-Graft with Navitel Delivery System in subjects with Abdominal Aortic Aneurysms (AAA).
Who Is on the Research Team?
Matthew Eagleton, MD
Principal Investigator
Cleveland Clinic Foundaton
Are You a Good Fit for This Trial?
This trial is for individuals with an infrarenal abdominal aortic aneurysm (AAA) that's over 4.5 cm in diameter for males, or over 4.0 cm for females, or has grown by at least half a centimeter in the past six months. It's not open to those who've had previous AAA repairs, are in other studies, have taken investigational drugs within 30 days or devices within a year, or have certain complications like dissection.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are treated with the Treovance Stent-Graft with Navitel Delivery System
Post-procedure Assessment
Post-procedure assessments prior to hospital discharge and at 30 days, 6 months, and 12 months post-implantation
Follow-up
Annual follow-up visits to monitor safety and effectiveness out to 5 years
What Are the Treatments Tested in This Trial?
Interventions
- Treovance Stent-Graft
Find a Clinic Near You
Who Is Running the Clinical Trial?
Bolton Medical
Lead Sponsor